AVS Announces Positive Safety and Effectiveness Data in First 95 Patients Treated in Pulse IVL IDE Study

Nov. 5, 2025 – Principal Investigator, Dr. Chris Metzger, Interventional Cardiologist at Ballad Health in Kingsport, TN, presented the results from the prospective, single-arm study designed to assess the safety and efficacy of AVS’s Pulse IVL™ System for the treatment of patients with moderate to severely calcified peripheral arterial disease.